Holding(s) in Company

AI SummaryClose X

Seneca Partners Limited has notified SkinBioTherapeutics PLC of a change in its major holding, with its voting rights decreasing from 9.9% to 4.08% as of January 14, 2026. This reduction, representing 10,561,405 voting rights, is attributed to an orderly sell-down over several years and dilution from increases in the issuer's share capital, with the 5% threshold being crossed on the notification date. The previous notification was made on April 19, 2021.

Disclaimer*

UK 100

Latest directors dealings